Clinical Endoscopy

The Korean Society of Gastrointestinal Endoscopy (대한소화기내시경학회)
권호 표지
DOI QR코드

DOI QR Code

Epidemiology of colonic adenoma and cancer

  • Dong Hyun Kim (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School)
  • Received : 2025.06.14
  • Accepted : 2025.07.13
  • Published : 2026.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Colorectal cancer (CRC) remains a major global health concern, showing significant variation in incidence and trends across different populations and age groups. While overall rates in older adults have declined in many high-income countries due to effective screening, the incidence of early-onset CRC, diagnosed before age 50, has been rising worldwide, especially in East Asia. Both early- and late-onset CRC share many risk factors, broadly categorized as modifiable and non-modifiable. Non-modifiable factors include age, sex, family history, hereditary syndromes, and inflammatory bowel disease. Modifiable factors such as obesity, unhealthy diet, physical inactivity, smoking, and alcohol consumption play a substantial role in CRC development and offer important targets for prevention. Lifestyle modifications-including weight control, regular physical activity, smoking cessation, and a balanced diet rich in fiber and vegetables-are associated with reduced CRC risk. In selected individuals, chemoprevention with low-dose aspirin may also lower CRC incidence. Screening and early detection remain essential strategies to reduce the CRC incidence and mortality, while comprehensive prevention efforts are needed to address the growing burden of CRC across diverse populations.

Keywords

References

  1. Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017;66: 683–691. https://doi.org/10.1136/gutjnl-2015-310912
  2. Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol 2021;22:1002–1013. https://doi.org/10.1016/S1470-2045(21)00199-6
  3. Li N, Lu B, Luo C, et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: a comparison among China, Europe, and northern America. Cancer Lett 2021;522:255–268. https://doi.org/10.1016/j.canlet.2021.09.034
  4. Siegel RL, Torre LA, Soerjomataram I, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut 2019;68:2179–2185.
  5. Ramadan M, Ghamdi H, Aboalola D, et al. Disease burden and projection of total and early-onset colorectal cancer in Gulf cooperation council countries from 1990 to 2019. Neoplasia 2024;51:100988. https://doi.org/10.1016/j.neo.2024.100988
  6. Onyoh EF, Hsu WF, Chang LC, et al. The rise of colorectal cancer in Asia: epidemiology, screening, and management. Curr Gastroenterol Rep 2019;21:36. https://doi.org/10.1007/s11894-019-0703-8
  7. Akimoto N, Ugai T, Zhong R, et al. Rising incidence of early-onset colorectal cancer: a call to action. Nat Rev Clin Oncol 2021;18:230–243. https://doi.org/10.1038/s41571-020-00445-1
  8. Ramadan M, Alsiary RA, Aboalola DA. Mortality-to-incidence ratio of early-onset colorectal cancer in high-income Asian and Middle Eastern countries: a systemic analysis of the Global Burden of Diseases Study 2019. Cancer Med 2023;12:20604–20616. https://doi.org/10.1002/cam4.v12.21
  9. Lu XQ, Li Y, Wang W, et al. International incidence trends in earlyand late-onset colorectal cancer: a population-based study. Int J Colorectal Dis 2020;35:1077–1086. https://doi.org/10.1007/s00384-020-03558-2
  10. Patel SG, Karlitz JJ, Yen T, et al. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol 2022;7:262–274. https://doi.org/10.1016/S2468-1253(21)00426-X
  11. Yang J, Du XL, Li ST, et al. Characteristics of differently located colorectal cancers support proximal and distal classification: a population-based study of 57,847 patients. PLoS One 2016;11:e0167540. https://doi.org/10.1371/journal.pone.0167540
  12. Yang L, Xiong Z, He W, et al. Proximal shift of colorectal cancer with increasing age in different ethnicities. Cancer Manag Res 2018; 10:2663–2673. https://doi.org/10.2147/CMAR
  13. Ahnen DJ, Wade SW, Jones WF, et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc 2014;89:216–224. https://doi.org/10.1016/j.mayocp.2013.09.006
  14. Cercek A, Chatila WK, Yaeger R, et al. A comprehensive comparison of early-onset and average-onset colorectal cancers. J Natl Cancer Inst 2021;113:1683–1692. https://doi.org/10.1093/jnci/djab124
  15. Chen FW, Sundaram V, Chew TA, et al. Advanced-stage colorectal cancer in persons younger than 50 years not associated with longer duration of symptoms or time to diagnosis. Clin Gastroenterol Hepatol 2017;15:728–737. https://doi.org/10.1016/j.cgh.2016.10.038
  16. McClelland PH, Liu T, Ozuner G. Early-onset colorectal cancer in patients under 50 years of age: demographics, disease characteristics, and survival. Clin Colorectal Cancer 2022;21:e135–e144. https://doi.org/10.1016/j.clcc.2021.11.003
  17. Demb J, Kolb JM, Dounel J, et al. Red flag signs and symptoms for patients with early-onset colorectal cancer: a systematic review and meta-analysis. JAMA Netw Open 2024;7:e2413157.
  18. Partridge AH, Hughes ME, Warner ET, et al. Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol 2016;34:3308–3314. https://doi.org/10.1200/JCO.2015.65.8013
  19. Gao XH, Li J, Liu LJ, et al. Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset colorectal cancer: a retrospective cohort study on 34067 patients managed from 2000 to 2021 in a Chinese tertiary center. Int J Surg 2022;104:106780. https://doi.org/10.1016/j.ijsu.2022.106780
  20. Ruiz-Grajales ÁE, Orozco-Puerta MM, Zheng S, et al. Clinical and pathological differences between early- and late-onset colorectal cancer and determinants of one-year all-cause mortality among advanced-stage patients: a retrospective cohort study in Medellín, Colombia. Cancer Treat Res Commun 2024;39:100797. https://doi.org/10.1016/j.ctarc.2024.100797
  21. Foppa C, Maroli A, Lauricella S, et al. Different oncologic outcomes in early-onset and late-onset sporadic colorectal cancer: a regression analysis on 2073 patients. Cancers (Basel) 2022;14:6239. https://doi.org/10.3390/cancers14246239
  22. Liao CK, Hsu YJ, Chern YJ, et al. Differences in characteristics and outcomes between early-onset colorectal cancer and late-onset colorectal cancers. Eur J Surg Oncol 2024;50:108687. https://doi.org/10.1016/j.ejso.2024.108687
  23. Alshenaifi JY, Vetere G, Maddalena G, et al. Mutational and co-mutational landscape of early onset colorectal cancer. Biomarkers 2025; 30:64–76. https://doi.org/10.1080/1354750X.2024.2447089
  24. Tang J, Peng W, Tian C, et al. Molecular characteristics of early-onset compared with late-onset colorectal cancer: a case controlled study. Int J Surg 2024;110:4559–4570.
  25. Ahn SM, Ansari AA, Kim J, et al. The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy. Oncotarget 2016;7:68638–68649. https://doi.org/10.18632/oncotarget.v7i42
  26. Kibriya MG, Raza M, Quinn A, et al. A transcriptome and methylome study comparing tissues of early and late onset colorectal carcinoma. Int J Mol Sci 2022;23:14261. https://doi.org/10.3390/ijms232214261
  27. Moiz S, Saha B, Mondal V, et al. Differential expression of miRNAs between young-onset and late-onset Indian colorectal carcinoma patients. Noncoding RNA 2025;11:10. https://doi.org/10.3390/ncrna11010010
  28. Leslie A, Carey FA, Pratt NR, et al. The colorectal adenoma-carcinoma sequence. Br J Surg 2002;89:845–860. https://doi.org/10.1046/j.1365-2168.2002.02120.x
  29. O'Brien MJ, Gibbons D. The adenoma-carcinoma sequence in colorectal neoplasia. Surg Oncol Clin N Am 1996;5:513–530. https://doi.org/10.1016/S1055-3207(18)30361-2
  30. Mitsuhashi S, Azari J, Dioguardi V, et al. Age matters: adenoma detection rates in average-risk screening patients aged 45 to 49 compared with those aged 50 to 54. J Clin Gastroenterol 2024;58:896–901. https://doi.org/10.1097/MCG.0000000000001953
  31. Bilal M, Holub J, Greenwald D, et al. Adenoma detection rates in 45-49-year-old persons undergoing screening colonoscopy: analysis from the GIQuIC registry. Am J Gastroenterol 2022;117:806–808. https://doi.org/10.14309/ajg.0000000000001684
  32. Ladabaum U, Shepard J, Mannalithara A. Adenoma and sessile serrated lesion detection rates at screening colonoscopy for ages 45-49 years vs older ages since the introduction of new colorectal cancer screening guidelines. Clin Gastroenterol Hepatol 2022;20:2895–2904. https://doi.org/10.1016/j.cgh.2022.04.037
  33. Liang PS, Williams JL, Dominitz JA, et al. Age-stratified prevalence and predictors of neoplasia among U.S. adults undergoing screening colonoscopy in a national endoscopy registry. Gastroenterology 2022;163:742–753. https://doi.org/10.1053/j.gastro.2022.05.036
  34. IJspeert JE, Vermeulen L, Meijer GA, et al. Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol 2015;12:401–409. https://doi.org/10.1038/nrgastro.2015.73
  35. Crockett SD, Nagtegaal ID. Terminology, molecular features, epidemiology, and management of serrated colorectal neoplasia. Gastroenterology 2019;157:949–966. https://doi.org/10.1053/j.gastro.2019.06.041
  36. De Palma FD, D'Argenio V, Pol J, et al. The molecular hallmarks of the serrated pathway in colorectal cancer. Cancers (Basel) 2019;11:1017. https://doi.org/10.3390/cancers11071017
  37. Bae JM, Kim JH, Kang GH. Molecular subtypes of colorectal cancer and their clinicopathologic features, with an emphasis on the serrated neoplasia pathway. Arch Pathol Lab Med 2016;140:406–412. https://doi.org/10.5858/arpa.2015-0310-RA
  38. Nishizawa T, Yoshida S, Toyoshima A, et al. Endoscopic diagnosis for colorectal sessile serrated lesions. World J Gastroenterol 2021; 27:1321–1329. https://doi.org/10.3748/wjg.v27.i13.1321
  39. Murakami T, Kurosawa T, Fukushima H, et al. Sessile serrated lesions: clinicopathological characteristics, endoscopic diagnosis, and management. Dig Endosc 2022;34:1096–1109. https://doi.org/10.1111/den.v34.6
  40. Tan CK, Suzuki S, Ang TL, et al. Sessile serrated lesion prevalence and factors associated with their detection: a post-hoc analysis of a multinational randomized controlled trial from Asia. Endoscopy 2024;56:684–693. https://doi.org/10.1055/a-2324-6262
  41. Kono Y, Higashi R, Mizushima H, et al. Usefulness of acetic acid spray with narrow-band imaging for identifying the margin of sessile serrated lesions. Dig Dis Sci 2023;68:2553–2560. https://doi.org/10.1007/s10620-022-07816-x
  42. Wolf AM, Fontham ET, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018;68:250–281. https://doi.org/10.3322/caac.v68.4
  43. Davidson KW, Barry MJ, Mangione CM, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 2021;325:1965–1977. https://doi.org/10.1001/jama.2021.6238
  44. Ullah F, Pillai AB, Omar N, et al. Early-onset colorectal cancer: current insights. Cancers (Basel) 2023;15:3202. https://doi.org/10.3390/cancers15123202
  45. Mauri G, Sartore-Bianchi A, Russo AG, et al. Early-onset colorectal cancer in young individuals. Mol Oncol 2019;13:109–131. https://doi.org/10.1002/mol2.2019.13.issue-2
  46. Aldhaleei WA, Wallace MB, Bhagavathula AS. Trends and age-period-cohort effect on the incidence of early-onset colorectal cancer (20-44 years) from 1990 to 2021 in the United States. Cancers (Basel) 2024;16:2883.
  47. Saraiva MR, Rosa I, Claro I. Early-onset colorectal cancer: a review of current knowledge. World J Gastroenterol 2023;29:1289–1303. https://doi.org/10.3748/wjg.v29.i8.1289
  48. Koo JH, Leong RW. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol 2010;25:33–42.
  49. González-Flores E, Garcia-Carbonero R, Élez E, et al. Gender and sex differences in colorectal cancer screening, diagnosis and treatment. Clin Transl Oncol 2025;27:2825–2837. https://doi.org/10.1007/s12094-024-03801-0
  50. Abotchie PN, Vernon SW, Du XL. Gender differences in colorectal cancer incidence in the United States, 1975-2006. J Womens Health (Larchmt) 2012;21:393–400. https://doi.org/10.1089/jwh.2011.2992
  51. White A, Ironmonger L, Steele RJC, et al. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer 2018;18:906. https://doi.org/10.1186/s12885-018-4786-7
  52. Wele P, Wu X, Shi H. Sex-dependent differences in colorectal cancer: with a focus on obesity. Cells 2022;11:3688. https://doi.org/10.3390/cells11223688
  53. Carethers JM. Racial and ethnic disparities in colorectal cancer incidence and mortality. Adv Cancer Res 2021;151:197–229. https://doi.org/10.1016/bs.acr.2021.02.007
  54. Augustus GJ, Ellis NA. Colorectal cancer disparity in African Americans: risk factors and carcinogenic mechanisms. Am J Pathol 2018;188:291–303. https://doi.org/10.1016/j.ajpath.2017.07.023
  55. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014;64:104–117. https://doi.org/10.3322/caac.v64.2
  56. Siegel RL, Wagle NS, Cercek A, et al. Colorectal cancer statistics, 2023. CA Cancer J Clin 2023;73:233–254. https://doi.org/10.3322/caac.v73.3
  57. Ladabaum U, Clarke CA, Press DJ, et al. Colorectal cancer incidence in Asian populations in California: effect of nativity and neighborhood-level factors. Am J Gastroenterol 2014;109:579–588. https://doi.org/10.1038/ajg.2013.488
  58. Strate LL, Syngal S. Hereditary colorectal cancer syndromes. Cancer Causes Control 2005;16:201–213.
  59. Kwak EL, Chung DC. Hereditary colorectal cancer syndromes: an overview. Clin Colorectal Cancer 2007;6:340–344.
  60. Chen L, Ye L, Hu B. Hereditary colorectal cancer syndromes: molecular genetics and precision medicine. Biomedicines 2022;10:3207. https://doi.org/10.3390/biomedicines10123207
  61. Goudarzi Y, Monirvaghefi K, Aghaei S, et al. Effect of genetic profiling on surgical decisions at hereditary colorectal cancer syndromes. Heliyon 2024;10:e34375.
  62. Ma H, Brosens LA, Offerhaus GJ, et al. Pathology and genetics of hereditary colorectal cancer. Pathology 2018;50:49–59. https://doi.org/10.1016/j.pathol.2017.09.004
  63. Macaron C, Leach BH, Burke CA. Hereditary colorectal cancer syndromes and genetic testing. J Surg Oncol 2015;111:103–111. https://doi.org/10.1002/jso.v111.1
  64. Lynch HT, Lynch JF, Lynch PM, et al. Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer 2008;7:27–39. https://doi.org/10.1007/s10689-007-9165-5
  65. Brosens LA, Offerhaus GJ, Giardiello FM. Hereditary colorectal cancer: genetics and screening. Surg Clin North Am 2015;95:1067–1080. https://doi.org/10.1016/j.suc.2015.05.004
  66. Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res 2009;29:2727–2737.
  67. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003;18 Suppl 2:1–5. https://doi.org/10.1046/j.1365-2036.18.s2.2.x
  68. Lutgens MW, Vleggaar FP, Schipper ME, et al. High frequency of early colorectal cancer in inflammatory bowel disease. Gut 2008; 57:1246–1251. https://doi.org/10.1136/gut.2007.143453
  69. Askling J, Dickman PW, Karlén P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001;120:1356–1362. https://doi.org/10.1053/gast.2001.24052
  70. Samadder NJ, Valentine JF, Guthery S, et al. Family history associates with increased risk of colorectal cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2019;17:1807–1813. https://doi.org/10.1016/j.cgh.2018.09.038
  71. Dyson JK, Rutter MD. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? World J Gastroenterol 2012;18:3839–3848. https://doi.org/10.3748/wjg.v18.i29.3839
  72. Esposito K, Chiodini P, Colao A, et al. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 2012;35:2402–2411. https://doi.org/10.2337/dc12-0336
  73. Ungvari Z, Fekete M, Varga P, et al. Overweight and obesity significantly increase colorectal cancer risk: a meta-analysis of 66 studies revealing a 25-57% elevation in risk. Geroscience 2025;47:3343–3364. https://doi.org/10.1007/s11357-024-01375-x
  74. Molla MD, Symonds EL, Winter JM, et al. Metabolic risk factors of colorectal cancer: umbrella review. Crit Rev Oncol Hematol 2024;204:104502.
  75. Pais R, Silaghi H, Silaghi AC, et al. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 2009;15:5141–5148. https://doi.org/10.3748/wjg.15.5141
  76. Ahmed RL, Schmitz KH, Anderson KE, et al. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006;107:28–36. https://doi.org/10.1002/cncr.v107:1
  77. Jin EH, Han K, Lee DH, et al. Association between metabolic syndrome and the risk of colorectal cancer diagnosed before age 50 years according to tumor location. Gastroenterology 2022;163:637–648. https://doi.org/10.1053/j.gastro.2022.05.032
  78. Chen H, Zheng X, Zong X, et al. Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer. Gut 2021;70:1147–1154.
  79. Aleksandrova K, Nimptsch K, Pischon T. Influence of obesity and related metabolic alterations on colorectal cancer risk. Curr Nutr Rep 2013;2:1–9. https://doi.org/10.1007/s13668-012-0036-9
  80. Kim JH, Lim YJ, Kim YH, et al. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev 2007;16:1543–1546. https://doi.org/10.1158/1055-9965.EPI-07-0199
  81. Botteri E, Borroni E, Sloan EK, et al. Smoking and colorectal cancer risk, overall and by molecular subtypes: a meta-analysis. Am J Gastroenterol 2020;115:1940–1949. https://doi.org/10.14309/ajg.0000000000000803
  82. Tsoi KK, Pau CY, Wu WK, et al. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 2009;7:682–688. https://doi.org/10.1016/j.cgh.2009.02.016
  83. Li H, Chen X, Hoffmeister M, et al. Associations of smoking with early- and late-onset colorectal cancer. JNCI Cancer Spectr 2023;7:pkad004.
  84. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001;10:725–731.
  85. Nakano S, Yamaji T, Shiraishi K, et al. Smoking and risk of colorectal cer according to KRAS and BRAF mutation status in a Japanese prospective Study. Carcinogenesis 2023;44:476–484. https://doi.org/10.1093/carcin/bgad046
  86. Wang X, Amitay E, Harrison TA, et al. Association between smoking and molecular subtypes of colorectal cancer. JNCI Cancer Spectr 2021;5:pkab056.
  87. Botteri E, Iodice S, Bagnardi V, et al. Smoking and colorectal cancer: a meta-analysis. JAMA 2008;300:2765–2778. https://doi.org/10.1001/jama.2008.839
  88. Bradbury KE, Murphy N, Key TJ. Diet and colorectal cancer in UK Biobank: a prospective study. Int J Epidemiol 2020;49:246–258. https://doi.org/10.1093/ije/dyz064
  89. Schwingshackl L, Schwedhelm C, Hoffmann G, et al. Food groups and risk of colorectal cancer. Int J Cancer 2018;142:1748–1758. https://doi.org/10.1002/ijc.v142.9
  90. Vieira AR, Abar L, Chan DS, et al. Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project. Ann Oncol 2017;28:1788–1802. https://doi.org/10.1093/annonc/mdx171
  91. Carroll KL, Frugé AD, Heslin MJ, et al. Diet as a risk factor for early-onset colorectal adenoma and carcinoma: a systematic review. Front Nutr 2022;9:896330. https://doi.org/10.3389/fnut.2022.896330
  92. Rychter AM, Łykowska-Szuber L, Zawada A, et al. Why does obesity as an inflammatory condition predispose to colorectal cancer? J Clin Med 2023;12:2451.
  93. Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology 2015;148:1244–1260. https://doi.org/10.1053/j.gastro.2014.12.035
  94. Baena R, Salinas P. Diet and colorectal cancer. Maturitas 2015;80:258–264. https://doi.org/10.1016/j.maturitas.2014.12.017
  95. Mahmood S, MacInnis RJ, English DR, et al. Domain-specific physical activity and sedentary behaviour in relation to colon and rectal cancer risk: a systematic review and meta-analysis. Int J Epidemiol 2017;46:1797–1813. https://doi.org/10.1093/ije/dyx137
  96. Harriss DJ, Atkinson G, Batterham A, et al. Lifestyle factors and colorectal cancer risk (2): a systematic review and meta-analysis of associations with leisure-time physical activity. Colorectal Dis 2009;11:689–701. https://doi.org/10.1111/cdi.2009.11.issue-7
  97. Morris JS, Bradbury KE, Cross AJ, et al. Physical activity, sedentary behaviour and colorectal cancer risk in the UK Biobank. Br J Cancer 2018;118:920–929. https://doi.org/10.1038/bjc.2017.496
  98. An S, Park S. Association of physical activity and sedentary behavior with the risk of colorectal cancer. J Korean Med Sci 2022;37:e158. https://doi.org/10.3346/jkms.2022.37.e158
  99. Shaw E, Farris MS, Stone CR, et al. Effects of physical activity on colorectal cancer risk among family history and body mass index subgroups: a systematic review and meta-analysis. BMC Cancer 2018;18:71. https://doi.org/10.1186/s12885-017-3970-5
  100. Haydon AM, Macinnis RJ, English DR, et al. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 2006;55:62–67. https://doi.org/10.1136/gut.2005.068189
  101. Roncucci L, Mariani F. Prevention of colorectal cancer: how many tools do we have in our basket? Eur J Intern Med 2015;26:752–756. https://doi.org/10.1016/j.ejim.2015.08.019
  102. Ungvari Z, Fekete M, Fekete JT, et al. Adherence to the Mediterranean diet and its protective effects against colorectal cancer: a meta-analysis of 26 studies with 2,217,404 participants. Geroscience 2025;47:1105–1121. https://doi.org/10.1007/s11357-024-01296-9
  103. Zhong Y, Zhu Y, Li Q, et al. Association between Mediterranean diet adherence and colorectal cancer: a dose-response meta-analysis. Am J Clin Nutr 2020;111:1214–1225. https://doi.org/10.1093/ajcn/nqaa083
  104. Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One 2013;8:e53916. https://doi.org/10.1371/journal.pone.0053916
  105. Luo J, Hendryx M, Manson JE, et al. Intentional weight loss and obesity-related cancer risk. JNCI Cancer Spectr 2019;3:pkz054. https://doi.org/10.1093/jncics/pkz054
  106. Mandic M, Safizadeh F, Niedermaier T, et al. Association of overweight, obesity, and recent weight loss with colorectal cancer risk. JAMA Netw Open 2023;6:e239556.
  107. Oruç Z, Kaplan MA. Effect of exercise on colorectal cancer prevention and treatment. World J Gastrointest Oncol 2019;11:348–366. https://doi.org/10.4251/wjgo.v11.i5.348
  108. Sanchez NF, Stierman B, Saab S, et al. Physical activity reduces risk for colon polyps in a multiethnic colorectal cancer screening population. BMC Res Notes 2012;5:312. https://doi.org/10.1186/1756-0500-5-312
  109. Nishihara R, Morikawa T, Kuchiba A, et al. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. Am J Epidemiol 2013;178:84–100. https://doi.org/10.1093/aje/kws431
  110. Park E, Kang HY, Lim MK, et al. Cancer risk following smoking cessation in Korea. JAMA Netw Open 2024;7:e2354958. https://doi.org/10.1001/jamanetworkopen.2023.54958
  111. Ordóñez-Mena JM, Walter V, Schöttker B, et al. Impact of prediagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium. Ann Oncol 2018;29:472–483. https://doi.org/10.1093/annonc/mdx761
  112. Chao A, Thun MJ, Jacobs EJ, et al. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst 2000;92:1888–1896. https://doi.org/10.1093/jnci/92.23.1888
  113. Katona BW, Weiss JM. Chemoprevention of colorectal cancer. Gastroenterology 2020;158:368–388. https://doi.org/10.1053/j.gastro.2019.06.047
  114. Veettil SK, Jinatongthai P, Nathisuwan S, et al. Efficacy and safety of chemopreventive agents on colorectal cancer incidence and mortality: systematic review and network meta-analysis. Clin Epidemiol 2018;10:1433–1445. https://doi.org/10.2147/CLEP
  115. Liang PS, Shaukat A, Crockett SD. AGA clinical practice update on chemoprevention for colorectal neoplasia: expert review. Clin Gastroenterol Hepatol 2021;19:1327–1336. https://doi.org/10.1016/j.cgh.2021.02.014
  116. Shaukat A, Kahi CJ, Burke CA, et al. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol 2021;116:458–479. https://doi.org/10.14309/ajg.0000000000001122
  117. Mohammed A, Yarla NS, Madka V, et al. Clinically relevant anti-inflammatory agents for chemoprevention of colorectal cancer: new perspectives. Int J Mol Sci 2018;19:2332. https://doi.org/10.3390/ijms19082332
  118. Heer E, Ruan Y, Mah B, et al. The efficacy of chemopreventive agents on the incidence of colorectal adenomas: a systematic review and network meta-analysis. Prev Med 2022;162:107169. https://doi.org/10.1016/j.ypmed.2022.107169
  119. Umezawa S, Higurashi T, Komiya Y, et al. Chemoprevention of colorectal cancer: past, present, and future. Cancer Sci 2019;110:3018–3026. https://doi.org/10.1111/cas.v110.10
  120. Dulai PS, Singh S, Marquez E, et al. Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis. BMJ 2016;355:i6188. https://doi.org/10.1136/bmj.i6188
  121. Ladabaum U, Dominitz JA, Kahi C, et al. Strategies for colorectal cancer screening. Gastroenterology 2020;158:418–432. https://doi.org/10.1053/j.gastro.2019.06.043
  122. Kanth P, Inadomi JM. Screening and prevention of colorectal cancer. BMJ 2021;374:n1855. https://doi.org/10.1136/bmj.n1855
  123. Simon K. Colorectal cancer development and advances in screening. Clin Interv Aging 2016;11:967–976. https://doi.org/10.2147/CIA
  124. Bretthauer M, Kaminski MF, Løberg M, et al. Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med 2016;176:894–902. https://doi.org/10.1001/jamainternmed.2016.0960
  125. Beran A, Aboursheid T, Ali AH, et al. Risk factors for inadequate bowel preparation in colonoscopy: a comprehensive systematic review and meta-analysis. Am J Gastroenterol 2024;119:2389–2397. https://doi.org/10.14309/ajg.0000000000003073
  126. Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697–706. https://doi.org/10.1056/NEJMoa1108895
  127. Young GP, Symonds EL, Allison JE, et al. Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci 2015;60:609–622. https://doi.org/10.1007/s10620-014-3445-3
  128. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014;370:1287–1297. https://doi.org/10.1056/NEJMoa1311194
  129. Ossandon MR, Agrawal L, Bernhard EJ, et al. Circulating tumor DNA assays in clinical cancer research. J Natl Cancer Inst 2018;110:929–934. https://doi.org/10.1093/jnci/djy105
  130. Campos-Carrillo A, Weitzel JN, Sahoo P, et al. Circulating tumor DNA as an early cancer detection tool. Pharmacol Ther 2020; 207:107458. https://doi.org/10.1016/j.pharmthera.2019.107458
  131. Zhang Y, Yao Y, Xu Y, et al. Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients. Nat Commun 2021;12:11. https://doi.org/10.1038/s41467-020-20162-8
  132. Alix-Panabières C, Pantel K. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discov 2016;6:479–491. https://doi.org/10.1158/2159-8290.CD-15-1483
  133. Jain S, Maque J, Galoosian A, et al. Optimal strategies for colorectal cancer screening. Curr Treat Options Oncol 2022;23:474–493. https://doi.org/10.1007/s11864-022-00962-4